GlassScriptPhysician profile
Robert T Dodge
NPI 1295721710
$310,817.91
in general payments reported to CMS, 2019-2025
10 companies · $77K in 2025
The $77K reported for 2025 was more than what 99% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $47K · 2022: $43K · 2023: $68K · 2024: $76K · 2025: $77K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $164K · Travel and Lodging: $34K · Food and Beverage: $12K · Consulting Fee: $10K · Education: $65.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $164,210.00 |
| Travel and Lodging | $34,479.72 |
| Food and Beverage | $12,486.07 |
| Consulting Fee | $10,130.00 |
| Education | $65.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $215,457.87 | 2021-2025 | Dovato, Apretude, Cabenuva |
| Gilead Sciences, INC. | $63,060.26 | 2021-2025 | Biktarvy, Descovy, Yeztugo |
| Merck Sharp & Dohme LLC | $17,420.31 | 2021-2025 | Pifeltro, Delstrigo, Isentress |
| Janssen Products, LP | $11,905.45 | 2021-2023 | Symtuza |
| Janssen Scientific Affairs, LLC | $1,263.52 | 2021-2023 | Symtuza |
| Janssen Biotech, INC. | $711.39 | 2021-2023 | Symtuza |
| Theratechnologies INC. | $568.81 | 2021-2023 | Trogarzo, Egrifta, Egrifta Sv |
| Napo Pharmaceuticals INC | $235.84 | 2021-2022 | |
| Abbvie INC. | $165.98 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $28.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Dodge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.